RARX - Ra Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents209,82270,381117,81219,386
Short Term Investments----
Net Receivables----
Inventory----
Other Current Assets----
Total Current Assets212,40772,877119,50220,186
Long Term Investments----
Property, plant and equipment5,1655,6065,5372,143
Goodwill183183183183
Intangible Assets131197262327
Accumulated Amortization----
Other Assets1,3341,3341,3341,503
Deferred Long Term Asset Charges----
Total Assets219,22080,197126,81824,342
Current Liabilities
Accounts Payable3,2454,3483,2521,319
Short/Current Long Term Debt----
Other Current Liabilities4793293034,345
Total Current Liabilities10,2018,6146,7376,938
Long Term Debt----
Other Liabilities1,9012,3992,859928
Deferred Long Term Liability Charges---40
Minority Interest----
Negative Goodwill----
Total Liabilities12,10211,0139,5967,866
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock4223231
Retained Earnings-188,157-123,214-68,764-39,900
Treasury Stock----
Capital Surplus395,233192,375185,9632,700
Other Stockholder Equity----
Total stockholders' equity207,11869,184117,222-37,199
Net Tangible Assets206,80468,804116,777-37,709